… In the current study, we focused on prevention using HPV vaccination … Control and Prevention
predicts that if the HPV vaccine would be administered with another mandatory vaccine, …

… HPV vaccines were developed to prevent cancer and save lives. To this effect, it may
help to train (future) healthcare workers (HCWs) to provide a strong recommendation of the …

… of the National Cancer Institute, NIH, are inventors of the HPV VLP vaccine technology …
and GlaxoSmithKline, that are developing the commercial HPV vaccines described herein. …

… cancer is an urgent research priority. In this article, we summarize what is known about the
effectiveness of HPV vaccines … forward to monitor progress toward cervical cancer elimination. …

… In summary, HPV vaccine development holds great promise for reducing the impact of
cervical cancer on the world’s women. Given the current state of technology, however, many …

… incidence and vice versa,39 thereby making possible an increase in disparities in cervical
cancer control if no action is undertaken to improve implementation of HPV vaccination in low- …

… the impact of HPV on the global burden of cancer and the potential benefit of HPV vaccination.
Approximately 5% of the world’s cancers are specifically attributed to HPV. While the …

… about whether prophylactic human papillomavirus vaccines will effectively prevent these …
human papillomavirus infection and the role of human papillomavirus in head and neck cancers…

… has stimulated the development of preventive and therapeutic HPV vaccines to control
HPV-… of HPV vaccines continues, we may generate effective strategies to control HPV-associated …

… We describe the state of the art of cancer control structures in the 27 … Information on cancer
plans, cancer registries, cancer … Nine countries had announced national HPV vaccination …